A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1
Clinical trial NCT00306631 · COMPLETED
Trial details
- NCT number
- NCT00306631
- Sponsor
- CASI pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2008-04-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.